Regulatory & Medical Affairs Director
Bio
Oleksandr Torhun, MBA, is an esteemed leader in life-science & healthcare industries for 20 years with expertise in regulatory strategies, compliance, and market entry within the pharma and biotech sectors. Educated in strategy at Harvard Business School, he's adept in market research and the intricacies of business development and regulatory affairs. At Otipharm Research, his strategic insight has been vital in market entry and global medical & regulatory affairs.
His tenure at a Ukrainian pharmaceutical manufacturer was marked by successfully managing 20 markets, and involved expanding into new markets like Australia. He has received recognition from WHO for his contributions to mRNA vaccine technology transfer. At Ukrainian manufacturer Biopharma-Plasma, he was instrumental in conducting clinical trials and medical affairs for plasma-derived products and biosimilars. With WHO, he facilitated faster access to essential medicines in a prequalification program.
Oleksandr's clinical background as a Neurosurgeon complements his regulatory expertise. He holds an MBA from Kyiv-Mohyla Business School, and actively participates in professional societies: Canadian Association of Professionals in Regulatory Affairs, Canada; Canada-Ukraine Chamber of Commerce Member, Canada; Regulatory Affairs Professionals Society, US; Society for Neuroscience, US.
